Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

37 trials

NCT07032662
Recruiting
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 2 · Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Colombia, Germany, Denmark, Estonia, Spain, Finland, United Kingdom, Greece, Hungary, Ireland, Italy, Mexico, Netherlands, Norway, Peru, Poland, Portugal, Romania, Serbia, Slovenia, Slovakia, United States · 136 sites
Registry update: 30 Sept 2026
NCT07461896
Recruiting
Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP
Not applicable · Italy · 1 site
Registry update: 5 Nov 2026
NCT06858579
Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Phase 3 · Argentina, Australia, Belgium, Bulgaria, Brazil, China, Colombia, Germany, Denmark, Spain, France, United Kingdom, Georgia, Croatia, Israel, Italy, Japan, South Korea, Latvia, North Macedonia, Malaysia, Netherlands, Philippines, Poland, Romania, Serbia, Eswatini, Thailand, United States, Vietnam · 175 sites
Registry update: 28 Oct 2026
NCT06714838
Recruiting
Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Phase 3 · Netherlands · 3 sites
Registry update: 4 Dec 2024
NCT06615622
Recruiting
Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and if This Method Aids Early Diagnosis, Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes.
Not applicable · Egypt · 1 site
Registry update: 3 Oct 2025
NCT06290141
Recruiting
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 3 · Argentina, Belgium, Brazil, Canada, Switzerland, China, Czechia, Germany, Denmark, Spain, France, United Kingdom, Greece, Hungary, Israel, Italy, Japan, Mexico, Norway, Poland, Portugal, Sweden, Taiwan, United States · 138 sites
Registry update: 19 Oct 2026
NCT06502015
Recruiting
Biomarkers in Autoimmune Disease of Nervous System
Not applicable · China · 1 site
Registry update: 29 Jul 2026
NCT06299748
Recruiting
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
Not applicable · Germany, Spain, Italy, United States · 4 sites
Registry update: 17 Feb 2026
NCT04929236
Recruiting
Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
Phase 3 · United States · 6 sites
Registry update: 5 Aug 2026
NCT06183645
Recruiting
Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.
Not applicable · Belgium · 1 site
Registry update: 12 Feb 2025
NCT04881682
Recruiting
Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 2 · Germany · 1 site
Registry update: 1 May 2026
NCT05327114
Recruiting
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 2/3 · Argentina, Australia, Canada, China, Colombia, Czechia, Germany, Spain, France, United Kingdom, Greece, Italy, Japan, South Korea, Mexico, Poland, Portugal, Taiwan, United States · 119 sites
Registry update: 3 Nov 2026
Conflicting statuses (updated in the registry within the last month)
NCT05584631
Recruiting
IVIG vs SCIG in CIDP
Phase 1 · United States · 1 site
Registry update: 11 Dec 2025
NCT04672733
Recruiting
Hizentra® in Inflammatory Neuropathies - pHeNIx Study
Not applicable · France · 27 sites
Registry update: 7 Jan 2025
NCT04561557
Recruiting
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
Early phase 1 · China · 1 site
Registry update: 30 Oct 2024
NCT04589299
Recruiting
Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)
Phase 4 · Denmark · 4 sites
Registry update: 17 May 2024
Conflicting statuses (not updated in the registry for 29 months)
NCT03684018
Recruiting
Two Dose Levels of Privigen in Pediatric CIDP
Phase 4 · United States · 9 sites
Registry update: 1 Jun 2026

Ordered by registry start date. Freshness and sponsorship never change the order.